ArticleClinical pharmacology and therapeutics2010

Study of the efficacy, biodistribution, and safety profile of therapeutic gutless adenovirus vectors as a prelude to a phase I clinical trial for glioblastoma.

A K M G Muhammad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.